P1.04-17 Phase I/II Study of Nivolumab and Vorolanib in Patients with Refractory Thoracic Tumors
| Autor: | Whisenant, J., Beckermann, K., Borghaei, H., Owonikoko, T., Patel, J., Berry, L., Shyr, Y., Harrow, K., Liang, C., Holzhausen, A., Selvaggi, G., Wakelee, H., Horn, L. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology October 2019 14(10) Supplement:S445-S446 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|